{"id":13855,"date":"2017-09-28T09:21:34","date_gmt":"2017-09-28T09:21:34","guid":{"rendered":"https:\/\/celonpharma.com\/?p=13855"},"modified":"2018-02-08T09:22:02","modified_gmt":"2018-02-08T09:22:02","slug":"an-interview-with-maciej-wieczorek-in-inwestorzy-tv","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/","title":{"rendered":"An interview with Maciej Wieczorek in inwestorzy.tv"},"content":{"rendered":"<p>President of the Board of Celon Pharma S.A. was a guest of the programme Profit. He answered Agniszka Zar\u0119ba\u2019s questions on the company\u2019s results for the first half of 2017, on its presence in international markets and the strategy of global commercialisation of the company\u2019s innovative portfolio.<br \/>\nWe invite you to view the video.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>President of the Board of Celon Pharma S.A. was a guest of the programme Profit. He answered Agniszka Zar\u0119ba\u2019s questions on the company\u2019s results for the first half of 2017, on its presence in international markets and the strategy of global commercialisation of the company\u2019s innovative portfolio. We invite you to view the video.<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[30],"tags":[],"class_list":["post-13855","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"President of the Board of Celon Pharma S.A. was a guest of the programme Profit. He answered Agniszka Zar\u0119ba\u2019s questions on the company\u2019s results for the first half of 2017, on its presence in international markets and the strategy of global commercialisation of the company\u2019s innovative portfolio. We invite you to view the video.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-28T09:21:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-08T09:22:02+00:00\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"An interview with Maciej Wieczorek in inwestorzy.tv\",\"datePublished\":\"2017-09-28T09:21:34+00:00\",\"dateModified\":\"2018-02-08T09:22:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/\"},\"wordCount\":66,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/\",\"name\":\"An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2017-09-28T09:21:34+00:00\",\"dateModified\":\"2018-02-08T09:22:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"An interview with Maciej Wieczorek in inwestorzy.tv\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/","og_locale":"en_US","og_type":"article","og_title":"An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma","og_description":"President of the Board of Celon Pharma S.A. was a guest of the programme Profit. He answered Agniszka Zar\u0119ba\u2019s questions on the company\u2019s results for the first half of 2017, on its presence in international markets and the strategy of global commercialisation of the company\u2019s innovative portfolio. We invite you to view the video.","og_url":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/","og_site_name":"Celon Pharma","article_published_time":"2017-09-28T09:21:34+00:00","article_modified_time":"2018-02-08T09:22:02+00:00","author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"An interview with Maciej Wieczorek in inwestorzy.tv","datePublished":"2017-09-28T09:21:34+00:00","dateModified":"2018-02-08T09:22:02+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/"},"wordCount":66,"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/","url":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/","name":"An interview with Maciej Wieczorek in inwestorzy.tv - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2017-09-28T09:21:34+00:00","dateModified":"2018-02-08T09:22:02+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/an-interview-with-maciej-wieczorek-in-inwestorzy-tv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"An interview with Maciej Wieczorek in inwestorzy.tv"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=13855"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13855\/revisions"}],"predecessor-version":[{"id":13856,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13855\/revisions\/13856"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=13855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=13855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=13855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}